Aqtual

Private

Hayward, CaliforniaHealthcare & Life Scienceshttps://aqtual.com/

Last Round

Series B

Jul 10, 2025

Total Funding Raised

$47M

Company Overview

Aqtual is a biotechnology company that develops precision medicine products for chronic disease management and oncology using a novel cell-free DNA-based platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision medicinecell-free DNAcfDNAliquid biopsyepigeneticsdiagnostic platformbiotechnologytranscriptomicstherapy response predictiononcology diagnosticsclinical decision supporthealthcare analyticsbiomarker discoverymolecular diagnosticsmulti-omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aqtual Comps

Public and private peers based on sector, stage, and business model.

Aqtual comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aqtual Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Jul 10, 2025
Series A	Oct 31, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Diana Abdueva

Founder CEO

Founding Team

Aqtual Investors

Notable investors and investment history

Aqtual investors
Investor	Rounds
Genoa Ventures	Series B, Series A
BOLD Capital Partners	Series B
Manta Ray Ventures	Series B, Series A
Yu Galaxy	Series B, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jul 10, 2025
$31M round completed.

View all signals

Aqtual Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Aqtual Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aqtual's valuation, stock price, and market status.

Firmographic Details

HeadquartersHayward, California

Employee Range34

Year Founded2018

Last FundingJul 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.